SEC-sourced researchBeta
CRBU
Caribou Biosciences, Inc.
Company comparison ↗
Data passport
- CIK
- 0001619856
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Mar 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 9,994,000.0000 | Mar 5, 2026 |
| December 2025 | 11,159,000.0000 | Mar 5, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 11,159,000.0000 | -148,125,000.0000 | -110,992,000.0000 | 175,367,000.0000 | 53,192,000.0000 | Mar 5, 2026 |
| December 2024 | 9,994,000.0000 | -149,105,000.0000 | -138,200,000.0000 | 313,313,000.0000 | 60,362,000.0000 | Mar 5, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $11.16M | December 2025 | Mar 5, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $9.99M | December 2024 | Mar 5, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$148.13M | December 2025 | Mar 5, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$110.99M | December 2025 | Mar 5, 2026 | 10-K |
| Total assetsAssets | $175.37M | December 2025 | Mar 5, 2026 | 10-K |
| Total liabilitiesLiabilities | $53.19M | December 2025 | Mar 5, 2026 | 10-K |